~/AI IN HEALTH/alphabet-s-isomorphic-labs-completes-massive-5-billion-series-c-funding

Alphabet's Isomorphic Labs Completes Massive $5 Billion Series C Funding

Alphabet's AI-driven drug discovery company Isomorphic Labs has completed a $5 billion Series C funding round led by Greenoaks and Sequoia Capital, with continued support from Alphabet and participation from new and existing investors. This massive capital injection provides Isomorphic Labs with substantial resources to accelerate its AI foundation models and scale up biological engineering infrastructure, potentially revolutionizing the traditional drug discovery timeline. The funding will be specifically directed toward advancing foundation simulation models, expanding internal and partnered drug candidate pipelines, and building global AI-powered biological engineering infrastructure.

## BACKGROUND

Founded in 2021 as a spin-off from DeepMind, Isomorphic Labs leverages cutting-edge artificial intelligence to transform the drug discovery process. The company builds upon breakthroughs like AlphaFold to develop proprietary AI models for designing new therapeutics.

## REFERENCES

## KEYWORDS

#AI in Healthcare#Drug Discovery#Isomorphic Labs#Alphabet#Funding

$ subscribe --daily